TrialJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2018

Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study.

Michael R McClung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.